172 related articles for article (PubMed ID: 35247749)
1. Nucleic acid actions on abnormal protein aggregation, phase transitions and phase separation.
Silva JL; Vieira TC; Cordeiro Y; de Oliveira GAP
Curr Opin Struct Biol; 2022 Apr; 73():102346. PubMed ID: 35247749
[TBL] [Abstract][Full Text] [Related]
2. Phase separation of the mammalian prion protein: Physiological and pathological perspectives.
do Amaral MJ; Freire MHO; Almeida MS; Pinheiro AS; Cordeiro Y
J Neurochem; 2023 Jul; 166(1):58-75. PubMed ID: 35149997
[TBL] [Abstract][Full Text] [Related]
3. Liquid-liquid phase separation and fibrillation of the prion protein modulated by a high-affinity DNA aptamer.
Matos CO; Passos YM; do Amaral MJ; Macedo B; Tempone MH; Bezerra OCL; Moraes MO; Almeida MS; Weber G; Missailidis S; Silva JL; Uversky VN; Pinheiro AS; Cordeiro Y
FASEB J; 2020 Jan; 34(1):365-385. PubMed ID: 31914616
[TBL] [Abstract][Full Text] [Related]
4. Arg177 and Asp159 from dog prion protein slow liquid-liquid phase separation and inhibit amyloid formation of human prion protein.
Li XN; Gao Y; Li Y; Yin JX; Yi CW; Yuan HY; Huang JJ; Wang LQ; Chen J; Liang Y
J Biol Chem; 2023 Nov; 299(11):105329. PubMed ID: 37805139
[TBL] [Abstract][Full Text] [Related]
5. Prion-Like Proteins in Phase Separation and Their Link to Disease.
Sprunger ML; Jackrel ME
Biomolecules; 2021 Jul; 11(7):. PubMed ID: 34356638
[TBL] [Abstract][Full Text] [Related]
6. The "Jekyll and Hyde" Actions of Nucleic Acids on the Prion-like Aggregation of Proteins.
Silva JL; Cordeiro Y
J Biol Chem; 2016 Jul; 291(30):15482-90. PubMed ID: 27288413
[TBL] [Abstract][Full Text] [Related]
7. Modulation of p53 and prion protein aggregation by RNA.
Cordeiro Y; Vieira T; Kovachev PS; Sanyal S; Silva JL
Biochim Biophys Acta Proteins Proteom; 2019 Oct; 1867(10):933-940. PubMed ID: 30826454
[TBL] [Abstract][Full Text] [Related]
8. Liquid-liquid phase transitions and amyloid aggregation in proteins related to cancer and neurodegenerative diseases.
de Oliveira GAP; Cordeiro Y; Silva JL; Vieira TCRG
Adv Protein Chem Struct Biol; 2019; 118():289-331. PubMed ID: 31928729
[TBL] [Abstract][Full Text] [Related]
9. Unraveling Prion Protein Interactions with Aptamers and Other PrP-Binding Nucleic Acids.
Macedo B; Cordeiro Y
Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28513534
[TBL] [Abstract][Full Text] [Related]
10. The N-terminal domain of the prion protein is required and sufficient for liquid-liquid phase separation: A crucial role of the Aβ-binding domain.
Kamps J; Lin YH; Oliva R; Bader V; Winter R; Winklhofer KF; Tatzelt J
J Biol Chem; 2021 Jul; 297(1):100860. PubMed ID: 34102212
[TBL] [Abstract][Full Text] [Related]
11. (Dys)functional insights into nucleic acids and RNA-binding proteins modulation of the prion protein and α-synuclein phase separation.
Cordeiro Y; Freire MHO; Wiecikowski AF; do Amaral MJ
Biophys Rev; 2023 Aug; 15(4):577-589. PubMed ID: 37681103
[TBL] [Abstract][Full Text] [Related]
12. Prion Protein Biology Through the Lens of Liquid-Liquid Phase Separation.
Agarwal A; Mukhopadhyay S
J Mol Biol; 2022 Jan; 434(1):167368. PubMed ID: 34808226
[TBL] [Abstract][Full Text] [Related]
13. Liquid-liquid phase separation of full-length prion protein initiates conformational conversion in vitro.
Tange H; Ishibashi D; Nakagaki T; Taguchi Y; Kamatari YO; Ozawa H; Nishida N
J Biol Chem; 2021; 296():100367. PubMed ID: 33545172
[TBL] [Abstract][Full Text] [Related]
14. Aggregation and degradation scales for prion-like domains: sequence features and context weigh in.
Cascarina SM; Ross ED
Curr Genet; 2019 Apr; 65(2):387-392. PubMed ID: 30310993
[TBL] [Abstract][Full Text] [Related]
15. The interplay between a GC-rich oligonucleotide and copper ions on prion protein conformational and phase transitions.
M Passos Y; J do Amaral M; C Ferreira N; Macedo B; Chaves JAP; E de Oliveira V; P B Gomes M; L Silva J; Cordeiro Y
Int J Biol Macromol; 2021 Mar; 173():34-43. PubMed ID: 33476618
[TBL] [Abstract][Full Text] [Related]
16. RNA buffers the phase separation behavior of prion-like RNA binding proteins.
Maharana S; Wang J; Papadopoulos DK; Richter D; Pozniakovsky A; Poser I; Bickle M; Rizk S; Guillén-Boixet J; Franzmann TM; Jahnel M; Marrone L; Chang YT; Sterneckert J; Tomancak P; Hyman AA; Alberti S
Science; 2018 May; 360(6391):918-921. PubMed ID: 29650702
[TBL] [Abstract][Full Text] [Related]
17. On the role of the cellular prion protein in the uptake and signaling of pathological aggregates in neurodegenerative diseases.
Legname G; Scialò C
Prion; 2020 Dec; 14(1):257-270. PubMed ID: 33345731
[TBL] [Abstract][Full Text] [Related]
18. The engineered peptide construct NCAM1-Aβ inhibits fibrillization of the human prion protein (PrP).
Gielnik M; Zhukova L; Zhukov I; Gräslund A; Kozak M; Wärmländer S
Acta Biochim Pol; 2022 Feb; 69(1):257-261. PubMed ID: 35143147
[TBL] [Abstract][Full Text] [Related]
19. Self-Replication of Prion Protein Fragment 89-230 Amyloid Fibrils Accelerated by Prion Protein Fragment 107-143 Aggregates.
Sneideris T; Ziaunys M; Chu BK; Chen RP; Smirnovas V
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33049945
[TBL] [Abstract][Full Text] [Related]
20. Ligand binding and hydration in protein misfolding: insights from studies of prion and p53 tumor suppressor proteins.
Silva JL; Vieira TC; Gomes MP; Bom AP; Lima LM; Freitas MS; Ishimaru D; Cordeiro Y; Foguel D
Acc Chem Res; 2010 Feb; 43(2):271-9. PubMed ID: 19817406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
